{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T12:39:23Z","timestamp":1720701563705},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.thromres.2005.03.014","type":"journal-article","created":{"date-parts":[[2005,5,25]],"date-time":"2005-05-25T11:44:44Z","timestamp":1117021484000},"page":"429-437","source":"Crossref","is-referenced-by-count":7,"title":["A combination of a thrombin inhibitor and dexamethasone prevents the development of experimental disseminated intravascular coagulation in rats"],"prefix":"10.1016","volume":"117","author":[{"given":"Margareta","family":"Elg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2005.03.014_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1055\/s-2007-995823","article-title":"Treatment options for clinically recognized disseminated intravascular coagulation","volume":"24","author":"Riewald","year":"1998","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2005.03.014_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-2007-995821","article-title":"Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock","volume":"24","author":"Vervloet","year":"1998","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2005.03.014_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-2007-995825","article-title":"Clinical experience with antithrombin III concentrates in critically ill patients with sepsis and multiple organ failure","volume":"24","author":"Eisele","year":"1998","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.thromres.2005.03.014_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1182\/blood.V74.1.165.165","article-title":"Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans","volume":"74","author":"Bauer","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2005.03.014_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1055\/s-0037-1615132","article-title":"Factor XI and protection of the fibrin clot against lysis\u2014a role for the intrinsic pathway of coagulation in fibrinolysis","volume":"80","author":"Bouma","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2005.03.014_bib6","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1016\/S0021-9258(18)83649-3","article-title":"The roles of protein C and thrombomodulin in the regulation of blood coagulation","volume":"264","author":"Esmon","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2005.03.014_bib7","doi-asserted-by":"crossref","first-page":"11023","DOI":"10.1073\/pnas.96.20.11023","article-title":"How the protease thrombin talks to cells","volume":"96","author":"Coughlin","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.thromres.2005.03.014_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/1050-1738(91)90001-U","article-title":"Plasminogen-activator inhibitors","volume":"1","author":"Schneiderman","year":"1991","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.thromres.2005.03.014_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00001721-199502000-00010","article-title":"Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy","volume":"6","author":"Saito","year":"1995","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.thromres.2005.03.014_bib10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0049-3848(00)00399-6","article-title":"The direct thrombin inhibitor melagatran and its oral prodrug H 376\/95: intestinal absorption properties, biochemical and pharmacodynamic effects","volume":"101","author":"Gustafsson","year":"2001","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2005.03.014_bib11","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s11886-004-0038-3","article-title":"New approaches to anticoagulation in atrial fibrillation","volume":"6","author":"Petersen","year":"2004","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.thromres.2005.03.014_bib12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1517\/13543784.10.5.845","article-title":"Advances in the development of thrombin inhibitors","volume":"10","author":"Steinmetzer","year":"2001","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.thromres.2005.03.014_bib13","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1055\/s-0037-1614245","article-title":"Effects of melagatran, a new low-molecular-weight thrombin inhibitor, on thrombin and fibrinolytic enzymes","volume":"79","author":"Gustafsson","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2005.03.014_bib14","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1055\/s-0037-1613445","article-title":"Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO III study","volume":"89","author":"Eriksson","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2005.03.014_bib15","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1056\/NEJMoa035162","article-title":"Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement","volume":"349","author":"Francis","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.thromres.2005.03.014_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2165\/00044011-200525010-00006","article-title":"Postoperative melagatran\/ximelagatran for the prevention of venous thromboembolism following major elective orthopaedic surgery: effects of timing of first dose and risk factors for thromboembolism and bleeding complications on efficacy and safety","volume":"25","author":"Dahl","year":"2005","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.thromres.2005.03.014_bib17","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa030104","article-title":"Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran","volume":"349","author":"Schulman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2005.03.014_bib18","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/S0140-6736(03)14841-6","article-title":"Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial","volume":"362","author":"Executive Steering Committee","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2005.03.014_bib19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0140-6736(03)14287-0","article-title":"Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial","volume":"362","author":"Wallentin","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2005.03.014_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0378-4347(01)00429-7","article-title":"Determination of melagatran, a novel direct thrombin inhibitor, in human plasma and urine by liquid chromatography-mass spectrometry","volume":"766","author":"Larsson","year":"2002","journal-title":"J Chromatogr, B, Biomed Sci Appl"},{"key":"10.1016\/j.thromres.2005.03.014_bib21","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1128\/MCB.9.6.2752","article-title":"Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin","volume":"9","author":"Gregory","year":"1989","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.thromres.2005.03.014_bib22","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1055\/s-0037-1615025","article-title":"Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation","volume":"79","author":"Gando","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2005.03.014_bib23","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1055\/s-0037-1615047","article-title":"Monocyte tissue factor (CD142) and Mac-1 (CD11b) are increased in septic patients","volume":"79","author":"Vickers","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2005.03.014_bib24","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/01.ATV.19.10.2517","article-title":"Endotoxin-induced activation of the coagulation cascade in humans: effect of acetylsalicylic acid and acetaminophen","volume":"19","author":"Pernerstorfer","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.thromres.2005.03.014_bib25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00001721-199909000-00002","article-title":"Prednisolone inhibits endotoxin-induced disseminated intravascular coagulation and improves mortality in rats: importance of inflammatory cytokine suppression","volume":"10","author":"Yamazaki","year":"1999","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.thromres.2005.03.014_bib26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1055\/s-0038-1650231","article-title":"Anti-thrombotic effect of a PAI-1 inhibitor in rats given endotoxin","volume":"75","author":"Abrahamsson","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2005.03.014_bib27","doi-asserted-by":"crossref","first-page":"16603","DOI":"10.1074\/jbc.271.28.16603","article-title":"TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin\u2013thrombomodulin complex","volume":"271","author":"Bajzar","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.thromres.2005.03.014_bib28","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0268-9499(97)80056-2","article-title":"Melagatran, and hirudin and heparin as adjuncts to tissue-type plasminogen activator in a canine model of coronary artery thrombolysis","volume":"11","author":"Mattsson","year":"1997","journal-title":"Fibrinolysis Proteolysis"},{"key":"10.1016\/j.thromres.2005.03.014_bib29","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1124\/dmd.31.3.294","article-title":"Absorption, distribution, metabolism, and excretion of ximelagatran, an oral direct thrombin inhibitor, in rats, dogs, and humans","volume":"31","author":"Eriksson","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.thromres.2005.03.014_bib30","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0002-9343(51)90022-8","article-title":"Effect of cortisone and ACTH on fluid and electrolyte distribution in man","volume":"11","author":"Levett","year":"1953","journal-title":"Am J Med"},{"key":"10.1016\/j.thromres.2005.03.014_bib31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00004872-198708000-00007","article-title":"Effects of ACTH and cortisol administration on blood pressure, electrolyte metabolism, atrial natriuretic peptide and renal function in normal man","volume":"5","author":"Connell","year":"1987","journal-title":"J Hypertens"},{"key":"10.1016\/j.thromres.2005.03.014_bib32","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0165-6147(98)01229-2","article-title":"Induction of cytokine receptors by glucocorticoids: functional and pathological significance","volume":"19","author":"Wiegers","year":"1998","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.thromres.2005.03.014_bib33","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1084\/jem.167.5.1708","article-title":"Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor","volume":"167","author":"Bertini","year":"1988","journal-title":"J Exp Med"},{"key":"10.1016\/j.thromres.2005.03.014_bib34","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJM198709103171101","article-title":"A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock","volume":"317","author":"Bone","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2005.03.014_bib35","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM198709103171102","article-title":"Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. The Veterans Administration Systemic Sepsis Cooperative Study Group","volume":"317","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2005.03.014_bib36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-141-1-200407060-00014","article-title":"Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose","volume":"141","author":"Minneci","year":"2004","journal-title":"Ann Intern Med"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384805001477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384805001477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T05:01:42Z","timestamp":1625979702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384805001477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0049384805001477"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2005.03.014","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}